PERMANENT AWARD EVIDENCE
University of Bristol · published 9 Feb 2026. This page preserves the identifiers and current held fields for one Contracts Finder release; it is not an invoice, performance assessment or complete contract history.
e8ea45e7-aa8d-44c9-aeec-ee8586ecb25c-882865ocds-b5fd17-fa402cb8-5c5e-4893-b7d2-c1a8c414f200GB-CFS-328328A tender estimate and an award value answer different questions. Neither is treated as cash paid.
Distribution of IMP to include the following activities: - Receipt of IMP from manufacturing company - Storage on IMP over the duration of the project under temperature controlled conditions - Receipt, check and confirm prescription - Suitable packaging of IMP/non IMP items - Delivery to participant home address (within 48hrs of receipt of prescription) at 5 timepoints - Maintain chain of custody and Accountability- IMPs must be traceable from the pharmacy to the participant, with temperature control, tamper-evident packaging, and delivery confirmation - Destruction of any left over IMP (or return to manufacturer) - Conducting such work as instructed, and in accordance with any relevant protocol / policy / work-instruction, for the duration of the contract. - Compliance with Medicines for Human Use (Clinical Trials) Regulations 2004 and the 2025 Amendment to Regulations when they are applied in April 2026 plus any other applicable regulatory requirements
The current projection contains one award release, not a verified chain of planning, tender, award, contract and modification records. Dates are shown in source-field order and are not silently repaired.
A company profile appears only when this release carries a usable company number. Name-only suppliers remain name-only.
No supplier is named in this projection. That does not prove the notice had no supplier in every source version.
Published 9 Feb 2026 · held through the daily award projection · Open Government Licence v3.0.